ID29309A - KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET - Google Patents

KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET

Info

Publication number
ID29309A
ID29309A IDW991574A ID991574A ID29309A ID 29309 A ID29309 A ID 29309A ID W991574 A IDW991574 A ID W991574A ID 991574 A ID991574 A ID 991574A ID 29309 A ID29309 A ID 29309A
Authority
ID
Indonesia
Prior art keywords
trombosis
arterial
inhibitors
prevention
factors
Prior art date
Application number
IDW991574A
Other languages
English (en)
Indonesian (id)
Inventor
Andre Bernat
Jean-Marc Herbert
Maurice Petitou
Ronald Van Amsterdam
Original Assignee
Sanofi Synthelabo Cs
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Cs, Akzo Nobel Nv filed Critical Sanofi Synthelabo Cs
Publication of ID29309A publication Critical patent/ID29309A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW991574A 1997-06-13 1998-06-09 KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET ID29309A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707368A FR2764511B1 (fr) 1997-06-13 1997-06-13 Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Publications (1)

Publication Number Publication Date
ID29309A true ID29309A (id) 2001-08-16

Family

ID=9507960

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991574A ID29309A (id) 1997-06-13 1998-06-09 KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET

Country Status (43)

Country Link
US (2) US6541488B1 (es)
EP (1) EP0986376B1 (es)
JP (1) JP3988803B2 (es)
KR (1) KR100598451B1 (es)
CN (1) CN1253150C (es)
AR (1) AR012247A1 (es)
AT (1) ATE384528T1 (es)
AU (1) AU728826B2 (es)
BR (1) BR9810520A (es)
CA (1) CA2293415C (es)
CO (1) CO4940476A1 (es)
CY (1) CY1107912T1 (es)
CZ (1) CZ299518B6 (es)
DE (1) DE69839046T2 (es)
DK (1) DK0986376T3 (es)
DZ (1) DZ2512A1 (es)
EE (1) EE04737B1 (es)
ES (1) ES2299209T3 (es)
FR (1) FR2764511B1 (es)
GT (1) GT199800171A (es)
HK (1) HK1032750A1 (es)
HR (1) HRP980322B1 (es)
HU (1) HU227956B1 (es)
ID (1) ID29309A (es)
IL (1) IL133452A (es)
IS (1) IS2619B (es)
ME (1) ME00685B (es)
MY (1) MY124648A (es)
NO (1) NO323739B1 (es)
NZ (1) NZ501452A (es)
PL (1) PL193405B1 (es)
PT (1) PT986376E (es)
RS (1) RS49902B (es)
RU (1) RU2212886C2 (es)
SA (1) SA98190552B1 (es)
SI (1) SI0986376T1 (es)
SK (1) SK286311B6 (es)
TR (1) TR199903087T2 (es)
TW (1) TW565442B (es)
UA (1) UA70919C2 (es)
UY (1) UY25044A1 (es)
WO (1) WO1998056365A1 (es)
ZA (1) ZA985137B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
WO2000047207A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company LACTAM INHIBITORS OF FXa AND METHOD
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
EP1370570B1 (en) * 2001-02-28 2007-01-24 John H. Griffin Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs
US20040067995A1 (en) 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
WO2004048363A1 (ja) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
EP1679067A4 (en) * 2003-09-19 2010-04-07 Kissei Pharmaceutical COMBINED MEDICINES
WO2005087266A1 (en) * 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
CN101820537B (zh) * 2004-04-23 2013-04-03 住友电气工业株式会社 活动图像数据的编码方法、终端装置以及双向对话型系统
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
JP5557410B2 (ja) * 2004-07-13 2014-07-23 第一三共株式会社 経口投与による血栓・塞栓の予防治療剤
US20070105825A1 (en) * 2004-09-16 2007-05-10 Yuji Hoyano Concurrent drugs
EP1991272A2 (en) * 2005-10-10 2008-11-19 N.V. Organon Antithrombotic compound
US20110150976A1 (en) * 2008-09-10 2011-06-23 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
JP6389009B2 (ja) * 2014-10-30 2018-09-12 チェンデュ バイユ ファーマシューティカル カンパニー リミテッドＣｈｅｎｇｄｕ Ｂａｉｙｕ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．，Ｌｔｄ． ギンコライドＢと第Ｘａ因子阻害剤とを含有する薬物組成物及びその製造方法と用途
CN106860868B (zh) * 2015-12-11 2019-11-22 北京百奥药业有限责任公司 沙班类药物与蚓激酶的药物组合物、制剂及其应用
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548189B1 (fr) * 1983-07-01 1986-04-11 Choay Sa Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
FR2728901B1 (fr) * 1994-12-28 1997-03-28 Sanofi Sa Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
IL129877A (en) 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Also Published As

Publication number Publication date
CN1274281A (zh) 2000-11-22
EP0986376B1 (fr) 2008-01-23
NO996137D0 (no) 1999-12-10
IL133452A (en) 2004-09-27
ATE384528T1 (de) 2008-02-15
ME00685B (me) 2008-08-07
PL193405B1 (pl) 2007-02-28
CO4940476A1 (es) 2000-07-24
EE9900574A (et) 2000-08-15
US20040092477A1 (en) 2004-05-13
MY124648A (en) 2006-06-30
EE04737B1 (et) 2006-12-15
BR9810520A (pt) 2000-09-19
GT199800171A (es) 2000-04-21
AR012247A1 (es) 2000-09-27
CZ446099A3 (cs) 2000-04-12
IL133452A0 (en) 2001-04-30
HRP980322A2 (en) 1999-04-30
ZA985137B (en) 1999-01-07
SK286311B6 (en) 2008-07-07
IS5280A (is) 1999-11-30
NZ501452A (en) 2002-06-28
FR2764511A1 (fr) 1998-12-18
HUP0002175A1 (hu) 2000-11-28
RU2212886C2 (ru) 2003-09-27
FR2764511B1 (fr) 2000-09-08
YU63699A (sh) 2002-06-19
JP3988803B2 (ja) 2007-10-10
IS2619B (is) 2010-05-15
JP2002504110A (ja) 2002-02-05
UA70919C2 (uk) 2004-11-15
NO323739B1 (no) 2007-07-02
AU728826B2 (en) 2001-01-18
DE69839046T2 (de) 2009-01-15
TW565442B (en) 2003-12-11
PL337288A1 (en) 2000-08-14
SK170999A3 (en) 2000-07-11
CA2293415A1 (en) 1998-12-17
NO996137L (no) 2000-02-14
SI0986376T1 (sl) 2008-06-30
DZ2512A1 (fr) 2003-02-01
HU227956B1 (en) 2012-07-30
TR199903087T2 (xx) 2000-05-22
SA98190552B1 (ar) 2006-09-09
DK0986376T3 (da) 2008-05-13
HUP0002175A3 (en) 2003-05-28
CN1253150C (zh) 2006-04-26
RS49902B (sr) 2008-08-07
PT986376E (pt) 2008-04-01
HK1032750A1 (en) 2001-08-03
CA2293415C (en) 2011-08-09
KR100598451B1 (ko) 2006-07-10
CY1107912T1 (el) 2013-09-04
ES2299209T3 (es) 2008-05-16
AU7924698A (en) 1998-12-30
CZ299518B6 (cs) 2008-08-20
UY25044A1 (es) 2000-10-31
KR20010013690A (ko) 2001-02-26
HRP980322B1 (en) 2003-12-31
WO1998056365A1 (fr) 1998-12-17
DE69839046D1 (de) 2008-03-13
US6541488B1 (en) 2003-04-01
EP0986376A1 (fr) 2000-03-22

Similar Documents

Publication Publication Date Title
ID29309A (id) KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET
HUP0002686A3 (en) Guanidine mimics as factor xa inhibitors and pharmaceutical compositions containing the same
ID25626A (id) Metoda untuk pembentukan pelapis film dan komposisi pelapisannya
IS5574A (is) Útskiptir Xa-þáttar oxóasaheterósýklýl-tálmar
ID17051A (id) Komposisi farmasi yang terdiri dari mirtazapine dan satu atau lebih inhibitor pengambilan kembali serotonin pilihan
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
NO975244D0 (no) 5-ring-heterocykluser som inhibitorer av leukocyttadhesjon og VLA-4-antagonister
DE69822395D1 (de) Flüssigkristalline harzzusammensetzung und geformte gegenstände
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
ID26279A (id) Film pengemas dan penggunaan film pengemas tersebut
NO975245D0 (no) Heterocykluser som inhibitorer av laukocyttadhesjon og VLA-4-antagonister
ZA200306488B (en) Benzamides and related inhibitors of factor Xa.
DE60017894D1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
NO306733B1 (no) Flytende rengjöringspreparat i form av tri-kritisk-punktblanding
ITMI20000106A0 (it) Composizione che inibisce la formazione di incrostazioni e/o la corrosione
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
ID30139A (id) Kompleks dari inhibitor ras-farnesiltransferase dan sulfobutileter-7- -siklodekstrin atau 2-hidroksipropil- -siklodekstrin dan metodanya
AU2003238475A1 (en) 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
DE69631655D1 (de) Harzzusammensetzung und laminat zur lagerung von flüssigen nahrungsmitteln
EP1194150A4 (en) USE OF NITROXIDES TO Heal Wounds And To Prevent Radiation Damage To Skin
ID26979A (id) Zat pelapis dan penggunaanya
ID19618A (id) Komposisi komposisi asam amino dan pemakaiannya dalam makanan untuk pengobatan
WO2002083160A3 (de) Mittel, die die apoptose bei an der wundheilung beteiligten zellen inhibieren
GB9820272D0 (en) Dissolution inhibitor of chemically amplified photoresist and chemically amplified photoresist composition containing the same
DE50013224D1 (de) Klebmassezusammensetzung und damit hergestellte Oberflächenschutzfolien